Literature DB >> 22872024

IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis.

Francesco Ciccia1, Riccardo Alessandro, Aroldo Rizzo, Stefania Raimondo, Annarita Giardina, Francesca Raiata, Luigi Boiardi, Alberto Cavazza, Giuliana Guggino, Giacomo De Leo, Carlo Salvarani, Giovanni Triolo.   

Abstract

OBJECTIVE: To study the expression of interleukin (IL)-33 and to evaluate its relationship with macrophage polarisation in artery biopsy specimens from patients with giant cell arteritis (GCA).
METHODS: IL-33, ST2, p-STAT-6 and perivascular IL-1 receptor-associated kinase 1 (p-IRAK1) tissue distribution was evaluated by immunohistochemistry. Inducible nitric oxide synthase and CD163 were also used by immunohistochemistry to evaluate the M1 and M2 polarisation, respectively. Quantitative gene expression analysis of IL-33, T-helper (Th)2-related transcription factor STAT6, Th2 cytokines (IL-4, IL-5, IL-25) and interferon (IFN)-γ was performed in artery biopsy samples obtained from 20 patients with GCA and 15 controls. Five additional patients who had received prednisone when the temporal artery biopsy was performed were also enrolled.
RESULTS: IFN-γ and IL-33 were significantly overexpressed in the inflamed arteries of GCA patients. IL-33 overexpression was not accompanied by a concomitant increase of Th2 cytokines. Neovessels scattered through the inflammatory infiltrates were the main sites of IL-33 expression. The expression of IL-33 receptor ST2 and of p-IRAK1 was also increased in GCA patients. Arteries from glucocorticoid-treated patients had a lower expression of IL-33. IL-33 was accompanied by the expression of p-STAT6 and a clear M2 macrophages polarisation.
CONCLUSIONS: A role for IL-33 in the inflammation of GCA patients is supported by these findings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872024     DOI: 10.1136/annrheumdis-2012-201309

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

Review 2.  [Biologics therapy for systemic lupus erythematosus. Current situation].

Authors:  B F Hoyer; T Dörner
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

3.  Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.

Authors:  Hui Zhang; Ryu Watanabe; Gerald J Berry; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2017-12-18       Impact factor: 29.690

Review 4.  Interleukin-9 and T helper type 9 cells in rheumatic diseases.

Authors:  F Ciccia; G Guggino; A Ferrante; P Cipriani; R Giacomelli; G Triolo
Journal:  Clin Exp Immunol       Date:  2016-08       Impact factor: 4.330

Review 5.  Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy
Journal:  Front Med (Lausanne)       Date:  2022-06-06

Review 6.  Immune mechanisms in medium and large-vessel vasculitis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Nat Rev Rheumatol       Date:  2013-11-05       Impact factor: 20.543

Review 7.  Drug Trafficking into Macrophages via the Endocytotic Receptor CD163.

Authors:  Jonas Heilskov Graversen; Søren Kragh Moestrup
Journal:  Membranes (Basel)       Date:  2015-06-23

Review 8.  The role of IL-33 in rheumatic diseases.

Authors:  Lihua Duan; Jie Chen; Feili Gong; Guixiu Shi
Journal:  Clin Dev Immunol       Date:  2013-09-15

9.  Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.

Authors:  Dae-Jun Kim; Seung-Ye Baek; Mi-Kyung Park; Kyung-Su Park; Jae Ho Lee; Sung-Hwan Park; Ho-Youn Kim; Seung-Ki Kwok
Journal:  J Korean Med Sci       Date:  2013-07-31       Impact factor: 2.153

10.  Significance of interleukin-33 and its related cytokines in patients with breast cancers.

Authors:  Jing Liu; Jia-Xin Shen; Jia-Lin Hu; Wen-He Huang; Guo-Jun Zhang
Journal:  Front Immunol       Date:  2014-04-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.